Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 781 to 795 of 1688 results for carers

  1. Zuranolone for treating severe postnatal depression ID6431

    In development [GID-TA11356] Expected publication date: TBC

  2. Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment ID6474

    In development [GID-TA11613] Expected publication date: TBC

  3. Linerixibat for treating pruritus in people with primary biliary cholangitis [ID6265]

    Awaiting development [GID-TA11307] Expected publication date: TBC

  4. Digital platforms for community based self-management of mild to moderate osteoarthritis and joint pain: Early value assessment

    Awaiting development [GID-HTE10057] Expected publication date: TBC

  5. Belzutifan with lenvatinib for treating advanced renal cell carcinoma after a PD-1 or PD-L1 inhibitor ID 6476

    Awaiting development [GID-TA11584] Expected publication date: TBC

  6. Efgartigimod with recombinant human hyaluronidase PH20 for treating chronic inflammatory demyelinating polyneuropathy ID6409

    In development [GID-TA11508] Expected publication date: TBC

  7. Mirvetuximab soravtansine for treating folate receptor alpha-positive platinum-resistant advanced epithelial ovarian, fallopian tube or primary peritoneal cancer ID6442

    In development [GID-TA11424] Expected publication date: TBC

  8. Pulsed field ablation for atrial fibrillation

    In development [GID-IPG10267] Expected publication date: 14 August 2025

  9. Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour

    In development [GID-IPG10408] Expected publication date: 16 April 2025

  10. Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer ID6346

    In development [GID-TA11405] Expected publication date: TBC

  11. Tobacco: preventing uptake, promoting quitting and treating dependence (NG209)

    This guideline covers support to stop smoking for everyone aged 12 and over, and help to reduce people's harm from smoking if they are not ready to stop in one go . It also covers ways to prevent children, young people and young adults aged 24 and under from taking up smoking. The guideline brings together and updates all NICE's previous guidelines on using tobacco, including smokeless tobacco . It covers nicotine replacement therapy and e-cigarettes to help people stop smoking or reduce their harm from smoking. It does not cover using tobacco products such as ‘heat not burn’ tobacco.

  12. Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]

    In development [GID-TA11036] Expected publication date: TBC

  13. Digital technologies to support smoking cessation in secondary care patients: early value assessment

    Awaiting development [GID-HTE10061] Expected publication date: TBC

  14. Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors (CG110)

    This guideline covers antenatal care for all pregnant women with complex social factors (particularly alcohol or drug misuse, recent migrant or asylum seeker status, difficulty reading or speaking English, aged under 20, domestic abuse). It offers advice on improving access to care, maintaining contact with antenatal carers, and additional information and support for these women.

  15. Tiragolumab with atezolizumab for treating advanced oesophageal squamous cell cancer after chemoradiotherapy [ID6267]

    Awaiting development [GID-TA11299] Expected publication date: TBC